Labelled compounds of interest as antitumour agents. Part 41. Deuteration and tritiation of a nitroimidazole-carborane designed for BNCT

This publication has 11 references indexed in Scilit:

• TcO(PnAO-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction
  Journal of Medicinal Chemistry, 1994
• Tumour-targetted boranes. Part 2. Coupling of closo-carboranes to substituted 2-nitroimidazoles via 1,3-dipolar cycloaddition
  Journal of the Chemical Society, Perkin Transactions 1, 1994
• The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer
  Angewandte Chemie International Edition in English, 1993
• Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study
  British Journal of Cancer, 1992
• Labelled compounds of interest as antitumour agents. Part III (1). Synthesis of 2H and 3H isotopomers of etanidazole (SR 2508)
  Journal of Labelled Compounds and Radiopharmaceuticals, 1990
• Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Boron neutron capture therapy for tumors
  International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
• Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Neutron-capture therapy of human cancer: in vitro results on the preparation of boron-labeled antibodies to carcinoembryonic antigen.
  Proceedings of the National Academy of Sciences, 1982
• Boron hydride derivatives for neutron capture therapy. Antibody approach
  Journal of Medicinal Chemistry, 1974